New marker could help doctors predict obesity-related disease risk

Researchers have identified a novel blood marker based on how the body processes omega-3 and omega-6 fatty acids that may indicate whether obese patients will develop serious metabolic complications. The finding could enable doctors to identify high-risk patients earlier and tailor interventions, potentially reducing costly complications like heart disease and diabetes.

Originaltitel: Omega-3 to omega-6 fatty acid oxidation ratio as a novel inflammation resolution marker for metabolic complications in obesity